المؤلفون: Maryam Avatefi, Fatemeh HadavandSiri, Seyed Saeed Hashemi Nazari, Mohammad Esmaeil Akbari

المصدر: Cancer Reports, Vol 7, Iss 1, Pp n/a-n/a (2024)

مصطلحات موضوعية: breast cancer, contralateral, disease‐free interval, risk factors, second primary, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2573-8348Test

الوصول الحر: https://doaj.org/article/600619c39b7045c2be9c4c659fc11f81Test

المؤلفون: S. F. Evdokimova, L. V. Bolotina, A. L. Kornietskaya, D. V. Sidorov, A. D. Kaprin, С. Ф. Евдокимова, Л. В. Болотина, А. Л. Корниецкая, Д. В. Сидоров, А. Д. Каприн

المصدر: Meditsinskiy sovet = Medical Council; № 22 (2023); 154-160 ; Медицинский Совет; № 22 (2023); 154-160 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: выживаемость без признаков болезни, metachronous metastases, adjuvant chemotherapy, radical resection, disease-free interval, unfavorable prognostic factors, liver metastases, disease-free survival, метахронные метастазы, адъювантная химиотерапия, радикальная резекция, безрецидивный интервал, факторы неблагоприятного прогноза, метастазы в печень

وصف الملف: application/pdf

العلاقة: https://www.med-sovet.pro/jour/article/view/8001/7090Test; Osterlund P, Salminen T, Soveri LM, Kallio R, Kellokumpu I, Lamminmäki A et al. Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study. Lancet Reg Health Eur. 2021;3:100049. https://doi.org/10.1016/j.lanepe.2021.100049Test.; Kunst N, Alarid-Escudero F, Aas E, Coupé VMH, Schrag D, Kuntz KM. Estimating Population-Based Recurrence Rates of Colorectal Cancer over Time in the United States. Cancer Epidemiol Biomarkers Prev. 2020;29(12):2710–2718. https://doi.org/10.1158/1055-9965.EPI-20-0490Test.; Duineveld LA, van Asselt KM, Bemelman WA, Smits AB, Tanis PJ, van Weert HC, Wind J. Symptomatic and Asymptomatic Colon Cancer Recurrence: A Multicenter Cohort Study. Ann Fam Med. 2016;14(3):215–220. https://doi.org/10.1370/afm.1919Test.; Haria PD, Baheti AD, Palsetia D, Ankathi SK, Choudhari A, Guha A et al. Follow-up of colorectal cancer and patterns of recurrence. Clin Radiol. 2021;76(12):908–915. https://doi.org/10.1016/j.crad.2021.07.016Test.; Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14(12):1208–1215. https://doi.org/10.1016/S1470-2045Test(13)70447-9.; Araujo RL, Gönen M, Herman P. Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis. Ann Surg Oncol. 2015;22(9):3070–3078. https://doi.org/10.1245/s10434-014-4354-6Test.; Kobayashi S, Beppu T, Honda G, Yamamoto M, Takahashi K, Endo I et al. Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases-a Japanese Nationwide Survey. J Gastrointest Surg. 2020;24(6):1244–1260. https://doi.org/10.1007/s11605-019-04250-9Test.; Wang ZM, Chen YY, Chen FF, Wang SY, Xiong B. Peri-operative chemotherapy for patients with resectable colorectal hepatic metastasis: A meta-analysis. Eur J Surg Oncol. 2015;41(9):1197–1203. https://doi.org/10.1016/j.ejso.2015.05.020Test.; Ciliberto D, Prati U, Roveda L, Barbieri V, Staropoli N, Abbruzzese A et al. Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and meta-analysis of randomized controlled trials. Oncol Rep. 2012;27(6):1849–1856. https://doi.org/10.3892/or.2012.1740Test.; Mitry E, Fields AL, Bleiberg H, Labianca R, Portier G, Tu D et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol. 2008;26(30):4906–4911. https://doi.org/10.1200/JCO.2008.17.3781Test.; Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol. 2006;24(31):4976–4982. https://doi.org/10.1200/JCO.2006.06.8353Test.; Ychou M, Raoul JL, Douillard JY, Gourgou-Bourgade S, Bugat R, Mineur L et al. A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802). Ann Oncol. 2009;20(4):674–680. https://doi.org/10.1093/annonc/mdn680Test.; Engstrand J, Nilsson H, Strömberg C, Jonas E, Freedman J. Colorectal cancer liver metastases – a population-based study on incidence, management and survival. BMC Cancer. 2018;18(1):78. https://doi.org/10.1186/s12885-017-3925-xTest.; Li J, Yuan Y, Yang F, Wang Y, Zhu X, Wang Z et al. Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition). J Hematol Oncol. 2019;12(1):16. https://doi.org/10.1186/s13045-019-0702-0Test.; Lumachi F, Chiara GB, Tozzoli R, Del Conte A, Basso SM. Factors Affecting Survival in Patients with Lung Metastases from Colorectal Cancer. A Short Meta-analysis. Anticancer Res. 2016;36(1):13–19. https://ar.iiarjournals.org/content/36/1/13.longTest.; Penna C, Nordlinger B. Colorectal metastasis (liver and lung). Surg Clin North Am. 2002;82(5):1075–1090. https://doi.org/10.1016/s0039-6109Test(02)00051-8.; Liu LL, Sun JD, Xiang ZL. Survival nomograms for colorectal carcinoma patients with lung metastasis and lung-only metastasis, based on the SEER database and a single-center external validation cohort. BMC Gastroenterol. 2022;22(1):446. https://doi.org/10.1186/s12876-022-02547-9Test.; Rahbari NN, Reissfelder C, Schulze-Bergkamen H, Jäger D, Büchler MW, Weitz J, Koch M. Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy. BMC Cancer. 2014;14:174. https://doi.org/10.1186/1471-2407-14-174Test.; Федянин МЮ, Гладков ОА, Гордеев СС, Карачун АМ, Козлов НА, Мамедли ЗЗ и др. Практические рекомендации по лекарственному лечению рака ободочной кишки, ректосигмоидного соединения и прямой кишки. Злокачественные опухоли. 2022;12(3s2–1):401–454. https://doi.org/10.18027/2224-5057-2022-12-3s2-401-454Test.; Kanemitsu Y, Shimizu Y, Mizusawa J, Inaba Y, Hamaguchi T, Shida D et al. Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial. J Clin Oncol. 2021;39(34):3789–3799. https://doi.org/10.1200/JCO.21.01032Test.; Mauri D, Zarkavelis G, Filis P, Tsali L, Zafeiri G, Papadaki A et al. Postoperative chemotherapy with single-agent fluoropyrimidines after resection of colorectal cancer liver metastases: a meta-analysis of randomised trials. ESMO Open. 2018;3(4):e000343. https://doi.org/10.1136/esmoopen-2018-000343Test.; Brandi G, De Lorenzo S, Nannini M, Curti S, Ottone M, Dall’Olio FG et al. Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis. World J Gastroenterol. 2016;22(2):519–533. https://doi.org/10.3748/wjg.v22.i2.519Test.; Park HS, Jung M, Shin SJ, Heo SJ, Kim CG, Lee MG et al. Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer. Ann Surg Oncol. 2016;23(3):928–935. https://doi.org/10.1245Test/ s10434-015-4951-z.; Zhang C, Tan Y, Xu H. Does adjuvant chemotherapy improve the prognosis of patients after resection of pulmonary metastasis from colorectal cancer? A systematic review and meta-analysis. Int J Colorectal Dis. 2019;34(10):1661–1671. https://doi.org/10.1007/s00384-019-03362-7Test.; Imanishi M, Yamamoto Y, Hamano Y, Yamada T, Moriwaki T, Gosho M et al. Efficacy of adjuvant chemotherapy after resection of pulmonary metastasis from colorectal cancer: a propensity score-matched analysis. Eur J Cancer. 2019;106:69–77. https://doi.org/10.1016/j.ejca.2018.10.003Test.; https://www.med-sovet.pro/jour/article/view/8001Test

الإتاحة: https://doi.org/10.21518/ms2023-453Test
https://doi.org/10.1016/j.lanepe.2021.100049Test
https://doi.org/10.1158/1055-9965.EPI-20-0490Test
https://doi.org/10.1370/afm.1919Test
https://doi.org/10.1016/j.crad.2021.07.016Test
https://doi.org/10.1016/S1470-2045Test(13)70447-9
https://doi.org/10.1245/s10434-014-4354-6Test
https://doi.org/10.1007/s11605-019-04250-9Test
https://doi.org/10.1016/j.ejso.2015.05.020Test
https://doi.org/10.3892/or.2012.1740Test

المؤلفون: Francesco Petrella, Federica Danuzzo, Maria Chiara Sibilia, Sara Vaquer, Raffaella Longarini, Alessandro Guidi, Federico Raveglia, Lidia Libretti, Emanuele Pirondini, Andrea Cara, Enrico Mario Cassina, Antonio Tuoro, Diego Cortinovis

المصدر: Cancers, Vol 16, Iss 7, p 1408 (2024)

مصطلحات موضوعية: colorectal cancer, pulmonary metastasectomy, disease free interval, overall survival, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2072-6694/16/7/1408Test; https://doaj.org/toc/2072-6694Test

الوصول الحر: https://doaj.org/article/861a2ab76c584bc3b64873b3813c1b60Test

المؤلفون: Liu, Jianfang, Lichtenberg, Tara, Hoadley, Katherine A, Poisson, Laila M, Lazar, Alexander J, Cherniack, Andrew D, Kovatich, Albert J, Benz, Christopher C, Levine, Douglas A, Lee, Adrian V, Omberg, Larsson, Wolf, Denise M, Shriver, Craig D, Thorsson, Vesteinn, Network, The Cancer Genome Atlas Research, Caesar-Johnson, Samantha J, Demchok, John A, Felau, Ina, Kasapi, Melpomeni, Ferguson, Martin L, Hutter, Carolyn M, Sofia, Heidi J, Tarnuzzer, Roy, Wang, Zhining, Yang, Liming, Zenklusen, Jean C, Zhang, Jiashan, Chudamani, Sudha, Liu, Jia, Lolla, Laxmi, Naresh, Rashi, Pihl, Todd, Sun, Qiang, Wan, Yunhu, Wu, Ye, Cho, Juok, DeFreitas, Timothy, Frazer, Scott, Gehlenborg, Nils, Getz, Gad, Heiman, David I, Kim, Jaegil, Lawrence, Michael S, Lin, Pei, Meier, Sam, Noble, Michael S, Saksena, Gordon, Voet, Doug, Zhang, Hailei, Bernard, Brady, Chambwe, Nyasha, Dhankani, Varsha, Knijnenburg, Theo, Kramer, Roger, Leinonen, Kalle, Liu, Yuexin, Miller, Michael, Reynolds, Sheila, Shmulevich, Ilya, Zhang, Wei, Akbani, Rehan, Broom, Bradley M, Hegde, Apurva M, Ju, Zhenlin, Kanchi, Rupa S, Korkut, Anil, Li, Jun, Liang, Han, Ling, Shiyun, Liu, Wenbin, Lu, Yiling, Mills, Gordon B, Ng, Kwok-Shing, Rao, Arvind, Ryan, Michael, Wang, Jing, Weinstein, John N, Zhang, Jiexin, Abeshouse, Adam, Armenia, Joshua, Chakravarty, Debyani, Chatila, Walid K, de Bruijn, Ino, Gao, Jianjiong, Gross, Benjamin E, Heins, Zachary J, Kundra, Ritika, La, Konnor, Ladanyi, Marc, Luna, Augustin, Nissan, Moriah G, Ochoa, Angelica, Phillips, Sarah M, Reznik, Ed, Sanchez-Vega, Francisco, Sander, Chris, Schultz, Nikolaus, Sheridan, Robert, Sumer, S Onur

المصدر: Cell. 173(2)

مصطلحات موضوعية: Biological Sciences, Bioinformatics and Computational Biology, Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Human Genome, Precision Medicine, Biotechnology, Cancer, Networking and Information Technology R&D (NITRD), Genetics, Cancer Genomics, Women's Health, Good Health and Well Being, Databases, Genetic, Genomics, Humans, Kaplan-Meier Estimate, Neoplasms, Proportional Hazards Models, Cancer Genome Atlas Research Network, Cox proportional hazards regression model, TCGA, The Cancer Genome Atlas, clinical data resource, disease-free interval, disease-specific survival, follow-up time, overall survival, progression-free interval, translational research, Medical and Health Sciences, Developmental Biology, Biological sciences, Biomedical and clinical sciences

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/9ng938g3Test
https://escholarship.org/content/qt9ng938g3/qt9ng938g3.pdfTest

المؤلفون: Congcong Chen, Zixiang Wu, Ziheng Wu, Chuanqiang Wu, Qi Wang, Tianwei Zhan, Lingjun Dong, Shuai Fang, Ming Wu

المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)

مصطلحات موضوعية: Second primary lung cancer, Type of surgery, Prognostic factors, Overall survival, Disease-free interval, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1471-2407Test

الوصول الحر: https://doaj.org/article/de9b77e479294efaabc8ec29151094e3Test

المؤلفون: Hiroyuki Yoshitake, Shoji Oura, Tomoyuki Yamaguchi, Shinichiro Makimoto

المصدر: Case Reports in Oncology, Vol 14, Iss 1, Pp 284-289 (2021)

مصطلحات موضوعية: long disease-free interval, normal psa level, prostate cancer, solitary lung metastasis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.karger.com/Article/FullText/512825Test; https://doaj.org/toc/1662-6575Test

الوصول الحر: https://doaj.org/article/b0cebe8a70e8466ba2c9546aa4a6449aTest

المؤلفون: Pedreira, Gonçalo Gomes Ferreira Marques

المساهمون: Mestrinho, Lisa Alexandra Pereira, Repositório da Universidade de Lisboa

مصطلحات موضوعية: Cão, neoplasia oral, margens cirúrgicas, recidiva local, intervalo livre de doença, fatores de prognóstico, Dog, oral neoplasia, surgical margins, local recurrence, disease-free interval, prognostic factors

وصف الملف: application/pdf

العلاقة: Pedreira GGFM 2019. Identificação e análise de variáveis com influência no intervalo livre de doença pós-cirúrgico de neoplasias malignas orais no cão : um estudo retrospetivo [dissertação de mestrado]. Lisboa: FMV-Universidade de Lisboa.

الإتاحة: http://hdl.handle.net/10400.5/19749Test

المؤلفون: WANG Juan, CHEN Youguo, ZHA Xueli, ZHOU Jinhua

المصدر: Zhongliu Fangzhi Yanjiu, Vol 47, Iss 1, Pp 58-62 (2020)

مصطلحات موضوعية: recurrent ovarian cancer, secondary cytoreductive surgery, disease free interval, progression free survival, overall survival after recurrence, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://html.rhhz.net/ZLFZYJ/html/8578.2020.19.0797.htmTest; https://doaj.org/toc/1000-8578Test

الوصول الحر: https://doaj.org/article/d58958da01b243078cca665404107856Test

المؤلفون: Zittel, Sven, Moratin, Julius, Horn, Dominik, Metzger, Karl, Ristow, Oliver, Engel, Michael, Mrosek, Jan, Freier, Kolja, Hoffmann, Jürgen, Freudlsperger, Christian

المصدر: http://lobid.org/resources/99370672697806441Test#!, 26(2):2055-2064.

مصطلحات موضوعية: Mouth Neoplasms/pathology [MeSH], Humans [MeSH], Salvage Therapy [MeSH], Salvage surgery, Treatment Outcome [MeSH], Retrospective Studies [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], Original Article, Neoplasm Staging [MeSH], Squamous Cell Carcinoma of Head and Neck [MeSH], Mouth Neoplasms/surgery [MeSH], Disease-free interval, Carcinoma, Squamous Cell/surgery [MeSH], Head and Neck Neoplasms [MeSH], Prognosis [MeSH], Recurrent oral squamous cell carcinoma, Squamous Cell/pathology [MeSH], Ablative surgery, Oral cancer

العلاقة: https://repository.publisso.de/resource/frl:6449138Test; https://doi.org/10.1007/s00784-021-04186-yTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816316Test/

الإتاحة: https://doi.org/10.1007/s00784-021-04186-yTest
https://repository.publisso.de/resource/frl:6449138Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816316Test/

المؤلفون: Congcong Chen (796149), Zixiang Wu (312334), Ziheng Wu (4493938), Chuanqiang Wu (3662500), Qi Wang (22418), Tianwei Zhan (10926504), Lingjun Dong (10926507), Shuai Fang (1779415), Ming Wu (238132)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Immunology, Cancer, Biological Sciences not elsewhere classified, Second primary lung cancer, Type of surgery, Prognostic factors, Overall survival, Disease-free interval

العلاقة: https://figshare.com/articles/journal_contribution/Additional_file_1_of_Therapeutic_method_for_early-stage_second_primary_non-small_lung_cancer_analysis_of_a_population-based_database/14737089Test

الإتاحة: https://doi.org/10.6084/m9.figshare.14737089.v1Test